Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.
Cancer Chemother Pharmacol
; 92(1): 1-6, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37199744
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hodgkin Disease
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Alemania